Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0007 | 0.00000010475 | 0.0001 |
Toxoplasma gondii | 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein | 0.0007 | 0 | 0.5 |
Echinococcus multilocularis | transient receptor potential cation channel | 0.0008 | 0.0012 | 0.0012 |
Echinococcus granulosus | transient receptor potential cation channel | 0.0007 | 0.00000010475 | 0.00000010487 |
Onchocerca volvulus | 0.0007 | 0 | 0.5 | |
Echinococcus granulosus | ankyrin repeat protein | 0.1333 | 0.9938 | 0.9949 |
Loa Loa (eye worm) | hypothetical protein | 0.0008 | 0.0012 | 1 |
Schistosoma mansoni | transient receptor potential channel | 0.0008 | 0.0012 | 0.0012 |
Echinococcus multilocularis | ankyrin repeat protein | 0.1333 | 0.9938 | 0.9938 |
Schistosoma mansoni | transient receptor potential channel | 0.0007 | 0.00000010475 | 0.00000010541 |
Leishmania major | hypothetical protein, conserved | 0.0007 | 0 | 0.5 |
Schistosoma mansoni | transient receptor potential cation channel subfamily A member | 0.1333 | 0.9938 | 1 |
Toxoplasma gondii | transporter, cation channel family protein | 0.0007 | 0 | 0.5 |
Trypanosoma brucei | inositol 1,4,5-trisphosphate receptor | 0.0007 | 0 | 0.5 |
Trypanosoma cruzi | inositol 1,4,5-trisphosphate receptor, putative | 0.0007 | 0 | 0.5 |
Echinococcus granulosus | transient receptor potential cation channel | 0.134 | 0.9988 | 1 |
Toxoplasma gondii | transporter, cation channel family protein | 0.0007 | 0 | 0.5 |
Echinococcus multilocularis | short transient receptor potential channel 6 | 0.0008 | 0.0012 | 0.0012 |
Leishmania major | hypothetical protein, unknown function | 0.0007 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0007 | 0.00000010475 | 0.0001 |
Echinococcus granulosus | short transient receptor potential channel 6 | 0.0008 | 0.0012 | 0.0012 |
Onchocerca volvulus | Transient receptor potential cation channel trpm homolog | 0.0007 | 0 | 0.5 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0007 | 0 | 0.5 |
Brugia malayi | olfactory channel protein osm-9 | 0.0008 | 0.0012 | 1 |
Toxoplasma gondii | 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein | 0.0007 | 0 | 0.5 |
Toxoplasma gondii | transporter, cation channel family protein | 0.0007 | 0 | 0.5 |
Trypanosoma brucei | Voltage-dependent calcium channel subunit, putative | 0.0007 | 0 | 0.5 |
Schistosoma mansoni | transient receptor potential channel | 0.0007 | 0.00000010475 | 0.00000010541 |
Toxoplasma gondii | hypothetical protein | 0.0007 | 0 | 0.5 |
Onchocerca volvulus | Transient receptor potential cation channel trpm homolog | 0.0007 | 0 | 0.5 |
Trypanosoma cruzi | Voltage-dependent calcium channel subunit, putative | 0.0007 | 0 | 0.5 |
Echinococcus multilocularis | transient receptor potential cation channel | 0.0007 | 0.00000010475 | 0.00000010475 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0007 | 0 | 0.5 |
Toxoplasma gondii | hypothetical protein | 0.0007 | 0 | 0.5 |
Echinococcus granulosus | transient receptor potential cation channel | 0.0008 | 0.0012 | 0.0012 |
Leishmania major | calcium channel protein, putative,ion transporter, putative | 0.0007 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 450 nM | Inhibition murine leukemia L1210 cell growth in culture | ChEMBL. | 3560161 |
IC50 (functional) | = 1800 nM | Inhibition of human colon tumor (HCT-8) cell growth in culture | ChEMBL. | 3560161 |
ILS (functional) | = 35 % | Percentage increase in life span of tumor bearing animals compared to non treated, tumor-bearing controls when treated at the optimal dose of 225 mg/kg/day ip (P388) | ChEMBL. | 3560161 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 3560161 | |
Mus musculus | ChEMBL23 | 3560161 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.